Overexpression of TDP-43 and HDAC6 in the late stage GBM patients raised the possibility that expression levels of TDP-43 and HDAC6 could be induced by cellular stress triggered by therapeutic treatment or nutrient deprivation that is common to highly malignant and advanced cancer cells (Figures 5 and 6). Here, TARDBP is linked to glioblastoma.